Literature DB >> 2672567

Baculovirus polyhedrin promoter-directed expression of rubella virus envelope glycoproteins, E1 and E2, in Spodoptera frugiperda cells.

C Oker-Blom1, R F Pettersson, M D Summers.   

Abstract

To study the capability of Spodoptera frugiperda (fall armyworm; Sf9) cells to synthesize and process mature rubella virus (RV) proteins, a cDNA encoding the structural envelope glycoproteins, E1 (58 kDa) and E2 (42-47 kDa) were inserted into the genome of Autographa californica nuclear polyhedrosis virus (AcNPV) and expressed during infection under the transcriptional regulation of the polyhedrin gene promoter. By immunoblot analysis with antibodies directed against purified RV, the individual proteins E1 and E2, and human convalescent serum, a polyprotein precursor migrating with an apparent molecular weight of 90-95 kDa was identified in Sf9 cells infected with the recombinant baculovirus, Ac701-RVE. In addition, two proteins migrating somewhat faster than authentic viral E1 and E2 were resolved. Pulse-chase labeling experiments in the absence and presence of tunicamycin, as well as treatment of the recombinant proteins with endo-beta-N-acetyl-D-glucosaminidase H indicated that the recombinant proteins are glycosylated and that the E1 and E2 apoproteins, respectively, were similar in size as compared to their in vitro synthesized counterparts. The recombinant protein products were further detected by some monoclonal antibodies directed against RV. The results presented here indicate that a polyprotein containing the envelope glycoproteins of RV is expressed and proteolytically cleaved in lepidopteran insect cells to form two proteins which resemble authentic E1 and E2. The baculovirus may therefore be suitable for the abundant expression of RV antigen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672567     DOI: 10.1016/0042-6822(89)90109-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Post-translational modifications in insect cells.

Authors:  H D Klenk
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

Review 2.  Laboratory diagnosis of rubella: past, present and future.

Authors:  J E Cradock-Watson
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

Review 3.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

4.  Structural requirements for the assembly of Norwalk virus-like particles.

Authors:  Andrea Bertolotti-Ciarlet; Laura J White; Rong Chen; B V Venkataram Prasad; Mary K Estes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Factors affecting recombinant Western equine encephalitis virus glycoprotein production in the baculovirus system.

Authors:  Ann M Toth; Christoph Geisler; Jared J Aumiller; Donald L Jarvis
Journal:  Protein Expr Purif       Date:  2011-08-16       Impact factor: 1.650

6.  Immunoaffinity purification of baculovirus-expressed rubella virus E1 for diagnostic purposes.

Authors:  C Lindqvist; M Schmidt; J Heinola; R Jaatinen; M Osterblad; A Salmi; S Keränen; K Akerman; C Oker-Blom
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

7.  Expression of recombinant E2 and C proteins of rubella virus in insect cells.

Authors:  M G Cusi; S Bianchi; L Cioè; P E Valensin
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein.

Authors:  Andrea Bertolotti-Ciarlet; Sue E Crawford; Anne M Hutson; Mary K Estes
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Diagnostic potential of baculovirus-expressed rubella virus envelope proteins.

Authors:  H Seppänen; M L Huhtala; A Vaheri; M D Summers; C Oker-Blom
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

10.  Reactivity of a recombinant rubella E1 antigen expressed in E. coli.

Authors:  P Londesborough; G Terry; L Ho-Terry
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.